Genetic Screening in Patients with Craniofacial Malformations

Abstract

Craniofacial malformations include a variety of anomalies, including cleft lip with or without cleft palate, craniosynostosis, microtia, and hemifacial microsomia. All of these anomalies can be either isolated or part of a defined genetic syndrome. A clinical geneticist or genetic counselor should be a member of the craniofacial team to help determine which patients have isolated anomalies and which are likely to have a syndrome. They would then arrange for the appropriate genetic testing to confirm the diagnosis of the specific syndrome. The identification of the specific syndrome is important for the overall care of the patient (as it identifies risk for other medical problems such as congenital heart defect) that will have to be taken into account in the care of the craniofacial malformation. In addition, knowing the specific syndrome will allow the family to understand how this happened to their child and the recurrence risk for future pregnancies. With the advent of new technologies, there are now many types of genetic testing available (including, karyotype, fluorescence in situ hybridization, chromosomal microarrays, and next generation sequencing) and the medical geneticist and genetic counselor can determine which specific testing is needed for a given patient.

Keywords

craniofacial anomalies - chromosomal microarrays - karyotype - next generation sequencing

• References

• 1 Leslie EJ, Marazita ML. Genetics of cleft lip and cleft palate. Am J Med Genet C Semin Med Genet 2013; 163C (4) 246-258
• 2 Marazita ML. The evolution of human genetic studies of cleft lip and cleft palate. Annu Rev Genomics Hum Genet 2012; 13 (1) 263-283
• 3 Dixon MJ, Marazita ML, Beaty TH, Murray JC. Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet 2011; 12 (3) 167-178
• 4 Agochukwu NB, Solomon BD, Doherty ES, Muenke M. Palatal and oral manifestations of Muenke syndrome (FGFR3-related craniosynostosis). J Craniofac Surg 2012; 23 (3) 664-668
• 5 Levi B, Brugman S, Wong VW, Grova M, Longaker MT, Wan DC. Palatogenesis: engineering, pathways and pathologies. Organogenesis 2011; 7 (4) 242-254
• 6 Mangold E, Ludwig KU, Nöthen MM. Breakthroughs in the genetics of orofacial clefting. Trends Mol Med 2011; 17 (12) 725-733
• 7 Zucchero TM, Cooper ME, Maher BS , et al. Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate. N Engl J Med 2004; 351 (8) 769-780
• 8 Cobourne MT. The complex genetics of cleft lip and palate. Eur J Orthod 2004; 26 (1) 7-16
• 9 Burdick AB. Genetic epidemiology and control of genetic expression in van der Woude syndrome. J Craniofac Genet Dev Biol Suppl 1986; 2 (Suppl): 99-105
• 10 Kondo S, Schutte BC, Richardson RJ , et al. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet 2002; 32 (2) 285-289
• 11 Brewer CM, Leek JP, Green AJ , et al. A locus for isolated cleft palate, located on human chromosome 2q32. Am J Hum Genet 1999; 65 (2) 387-396
• 12 Venkatesh R. Syndromes and anomalies associated with cleft. Indian J Plast Surg 2009; 42 (3, Suppl): S51-S55
• 13 Schilbach U, Rott HD. Ocular hypotelorism, submucosal cleft palate, and hypospadias: a new autosomal dominant syndrome. Am J Med Genet 1988; 31 (4) 863-870
• 14 Glass IA, Swindlehurst CA, Aitken DA, McCrea W, Boyd E. Interstitial deletion of the long arm of chromosome 2 with normal levels of isocitrate dehydrogenase. J Med Genet 1989; 26 (2) 127-130
• 15 FitzPatrick DR, Carr IM, McLaren L , et al. Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum Mol Genet 2003; 12 (19) 2491-2501
• 16 McCarthy JG, Warren SM, Bernstein J , et al; Craniosynostosis Working Group. Parameters of care for craniosynostosis. Cleft Palate Craniofac J 2012; 49 (Suppl): 1S-24S
• 17 Robin NH, Falk MJ, Haldeman-Englert CR. FGFR-Related Craniosynostosis Syndromes. In: Pagon RA, Adam MP, Ardinger HH, , et al; GeneReviews, eds. Seattle, WA: University of Washington; 1993. http://www.ncbi.nlm.nih.gov/books
• 18 Luquetti DV, Heike CL, Hing AV, Cunningham ML, Cox TC. Microtia: epidemiology and genetics. Am J Med Genet A 2012; 158A (1) 124-139
• 19 Alasti F, Van Camp G. Genetics of microtia and associated syndromes. J Med Genet 2009; 46 (6) 361-369
• 20 Dauwerse JG, Dixon J, Seland S , et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet 2011; 43 (1) 20-22
• 21 Driscoll DA, Salvin J, Sellinger B , et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet 1993; 30 (10) 813-817
• 22 Bernier FP, Caluseriu O, Ng S , et al; FORGE Canada Consortium. Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome. Am J Hum Genet 2012; 90 (5) 925-933